You just read:

Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to be Used for Viral Infections

News provided by

Excision BioTherapeutics Inc.

Nov 13, 2017, 09:01 ET